Wolverine Asset Management LLC Buys New Stake in Intelligent Medicine Acquisition Corp. (NASDAQ:IQMD)

Wolverine Asset Management LLC purchased a new position in Intelligent Medicine Acquisition Corp. (NASDAQ:IQMDGet Rating) in the 4th quarter, HoldingsChannel reports. The fund purchased 10,000 shares of the company’s stock, valued at approximately $99,000.

Separately, Dupont Capital Management Corp acquired a new position in shares of Intelligent Medicine Acquisition in the fourth quarter worth $255,000. Hedge funds and other institutional investors own 25.60% of the company’s stock.

NASDAQ:IQMD opened at $9.97 on Friday. The stock has a fifty day simple moving average of $9.99. Intelligent Medicine Acquisition Corp. has a 52 week low of $9.86 and a 52 week high of $10.93.

About Intelligent Medicine Acquisition (Get Rating)

Intelligent Medicine Acquisition Corp. does not have significant operations. The company focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses. It intends to identify business opportunities in the field of life science.

Featured Stories

Want to see what other hedge funds are holding IQMD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intelligent Medicine Acquisition Corp. (NASDAQ:IQMDGet Rating).

Institutional Ownership by Quarter for Intelligent Medicine Acquisition (NASDAQ:IQMD)

Receive News & Ratings for Intelligent Medicine Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intelligent Medicine Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.